Question 1

Which peptides are marketed as nootropics?

Accepted Answer

Semax, Selank, DSIP, Dihexa, Cerebrolysin (a multi-peptide preparation), and indirectly BDNF and various growth-factor compounds. None is MHRA-licensed for cognitive enhancement.

Question 2

Do nootropic peptides improve cognition in healthy adults?

Accepted Answer

No Western Phase 3 cognitive-enhancement trial supports any of these for healthy-adult cognitive improvement. Russian-jurisdiction clinical evidence exists for specific neurological indications (stroke recovery for Semax / Cerebrolysin; anxiety for Selank), not for healthy-adult 'smart drug' use.

Question 3

Is Selank safer than benzodiazepines?

Accepted Answer

Selank does not appear to cause physical dependence in the available evidence. Long-term safety data are limited. 'Safer than benzodiazepines' is a comparative claim that needs comparative trials — none exists. NHS Talking Therapies + licensed UK anxiolytics is the evidence-based first-line for anxiety.

Question 4

Is Semax effective for cognition?

Accepted Answer

Russian-licensed for stroke recovery and cognitive impairment. Western Phase 3 healthy-adult cognitive-enhancement data are absent. Some users report nootropic effects; trial replication is limited.

Question 5

What about Cerebrolysin?

Accepted Answer

Multi-peptide preparation from porcine brain tissue. Licensed in many European, Asian, and Latin American countries for stroke recovery and dementia. NOT MHRA-licensed in the UK. Not part of NHS pathways for any condition.

Question 6

Is Dihexa safe to take?

Accepted Answer

Essentially no human safety data. Theoretical HGF / c-Met oncologic concerns. The compound is preclinical-only. We do not recommend any unlicensed compound with no human safety profile.

Question 7

Are these peptides legal in the UK?

Accepted Answer

None is MHRA-licensed. Personal-use importation sits in regulatory grey area; sale with cognitive-enhancement claims engages UK medicines regulation.

Question 8

What is the evidence-based pathway for cognitive complaints?

Accepted Answer

GP review (rule out treatable causes — sleep apnoea, depression, thyroid, B12, ADHD), NHS Talking Therapies for mood-driven cognitive symptoms, adult ADHD assessment if attention concerns are lifelong, NHS memory clinic for genuine cognitive decline. Exercise, sleep, social engagement, novel learning — the strongest lifestyle interventions.

Question 9

Can I combine these with prescribed medications?

Accepted Answer

Interactions with SSRIs, stimulants, benzodiazepines, and other CNS medicines are uncharacterised. Combining unlicensed peptides with prescribed psychotropics is uncharted ground. Discuss any consideration honestly with your prescriber.

Question 10

What about BDNF supplements?

Accepted Answer

Mechanistically implausible — BDNF cannot cross the blood-brain barrier. Exercise raises endogenous BDNF; that is the practical intervention.

Cognitive peptides — frequently asked questions

Related

Cognitive peptides — frequently asked questions

Related